Roy M - Search Results

1

Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.

Aguilar C, Lenoir C, Lambert N, Bègue B, Brousse N, Canioni D, Berrebi D, Roy M, Gérart S, Chapel H, Schwerd T, Siproudhis L, Schäppi M, Al-Ahmari A, Mori M, Yamaide A, Galicier L, Neven B, Routes J, Uhlig HH, Koletzko S, Patel S, Kanegane H, Picard C, Fischer A, Bensussan NC, Ruemmele F, Hugot JP, Latour S. Aguilar C, et al. Among authors: roy m. J Allergy Clin Immunol. 2014 Nov;134(5):1131-41.e9. doi: 10.1016/j.jaci.2014.04.031. Epub 2014 Jun 15. J Allergy Clin Immunol. 2014. PMID: 24942515 Clinical Trial.

2

Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease.

Petit CS, Barreau F, Besnier L, Gandille P, Riveau B, Chateau D, Roy M, Berrebi D, Svrcek M, Cardot P, Rousset M, Clair C, Thenet S. Petit CS, et al. Among authors: roy m. Gastroenterology. 2012 Jul;143(1):122-32.e15. doi: 10.1053/j.gastro.2012.03.029. Epub 2012 Mar 22. Gastroenterology. 2012. PMID: 22446194

3

Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, Léger T, Ben-Mkaddem S, Berrebi D, Dussaillant M, Alnabhani Z, Roy M, Bonacorsi S, Wolf-Watz H, Perroy J, Ollendorff V, Hugot JP. Meinzer U, et al. Among authors: roy m. Cell Host Microbe. 2012 Apr 19;11(4):337-51. doi: 10.1016/j.chom.2012.02.009. Cell Host Microbe. 2012. PMID: 22520462 Free article.

4

Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling.

Jung C, Meinzer U, Montcuquet N, Thachil E, Château D, Thiébaut R, Roy M, Alnabhani Z, Berrebi D, Dussaillant M, Pedruzzi E, Thenet S, Cerf-Bensussan N, Hugot JP, Barreau F. Jung C, et al. Among authors: roy m. J Clin Invest. 2012 Jun;122(6):2239-51. doi: 10.1172/JCI58147. Epub 2012 May 8. J Clin Invest. 2012. PMID: 22565313 Free PMC article.

5

Digestive perianastomotic ulcerations and Crohn's disease.

Frémond ML, Viala J, Tréton X, Roy M, Berrebi D, Gottrand F, Bonnard A, Martinez-Vinson C, Hugot JP. Frémond ML, et al. Among authors: roy m. J Crohns Colitis. 2014 Dec;8(12):1624-31. doi: 10.1016/j.crohns.2014.06.011. Epub 2014 Aug 6. J Crohns Colitis. 2014. PMID: 25107846

6

Pseudomonas fluorescens alters the intestinal barrier function by modulating IL-1β expression through hematopoietic NOD2 signaling.

Alnabhani Z, Montcuquet N, Biaggini K, Dussaillant M, Roy M, Ogier-Denis E, Madi A, Jallane A, Feuilloley M, Hugot JP, Connil N, Barreau F. Alnabhani Z, et al. Among authors: roy m. Inflamm Bowel Dis. 2015 Mar;21(3):543-55. doi: 10.1097/MIB.0000000000000291. Inflamm Bowel Dis. 2015. PMID: 25659087

7

NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.

Boukercha A, Mesbah-Amroun H, Bouzidi A, Saoula H, Nakkemouche M, Roy M, Hugot JP, Touil-Boukoffa C. Boukercha A, et al. Among authors: roy m. World J Gastroenterol. 2015 Jul 7;21(25):7786-94. doi: 10.3748/wjg.v21.i25.7786. World J Gastroenterol. 2015. PMID: 26167078 Free PMC article.

8

Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis.

Alnabhani Z, Hugot JP, Montcuquet N, Le Roux K, Dussaillant M, Roy M, Leclerc M, Cerf-Bensussan N, Lepage P, Barreau F. Alnabhani Z, et al. Among authors: roy m. Inflamm Bowel Dis. 2016 Apr;22(4):763-73. doi: 10.1097/MIB.0000000000000749. Inflamm Bowel Dis. 2016. PMID: 26963567

9

Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect.

Al Nabhani Z, Lepage P, Mauny P, Montcuquet N, Roy M, Le Roux K, Dussaillant M, Berrebi D, Hugot JP, Barreau F. Al Nabhani Z, et al. Among authors: roy m. J Crohns Colitis. 2016 Dec;10(12):1428-1436. doi: 10.1093/ecco-jcc/jjw095. Epub 2016 May 4. J Crohns Colitis. 2016. PMID: 27147452

10

Complementary Roles of Nod2 in Hematopoietic and Nonhematopoietic Cells in Preventing Gut Barrier Dysfunction Dependent on MLCK Activity.

Al Nabhani Z, Montcuquet N, Roy M, Dussaillant M, Hugot JP, Barreau F. Al Nabhani Z, et al. Among authors: roy m. Inflamm Bowel Dis. 2017 Jul;23(7):1109-1119. doi: 10.1097/MIB.0000000000001135. Inflamm Bowel Dis. 2017. PMID: 28520587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,268 results

Search Page

Filters